Eagle Pharmaceuticals, Inc.
FULVESTRANT FORMULATIONS
Last updated:
Abstract:
Fulvestrant formulations suitable for intramuscular injection at concentration in excess of 40 mg/ml in the absence of castor oil and castor oil derivatives are disclosed.
Status:
Application
Type:
Utility
Filling date:
16 Sep 2020
Issue date:
26 Aug 2021